Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents: author's reply
- PMID: 34936911
- DOI: 10.1016/j.jclinepi.2021.12.021
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents: author's reply
Keywords: ADHD; Clinical trials; Drug authorizations; Methylphenidate; Psychiatry; Regulatory agencies.
Comment on
-
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documents.J Clin Epidemiol. 2022 Mar;143:242-253. doi: 10.1016/j.jclinepi.2021.10.027. Epub 2021 Nov 6. J Clin Epidemiol. 2022. PMID: 34752938
-
Missing trials from regulatory document of methylphenidate for adults with attention-deficit/hyperactivity disorder: Response to Boesen et al.J Clin Epidemiol. 2022 May;145:185-186. doi: 10.1016/j.jclinepi.2021.12.020. Epub 2021 Dec 16. J Clin Epidemiol. 2022. PMID: 34923025 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
